Search

everythinglearnresearchcommunity

for

Search:↓

The safety and tolerability of low-dose oral minoxidil for treating hair loss in adolescents is not clearly determined.

Standard intralesional corticosteroids are the best treatment for patchy alopecia areata.

The Brigham Eyelash Tool for Alopecia (BELA) is a reliable way to measure eyelash loss in alopecia areata patients.

1% anthralin ointment is effective and safe for treating severe alopecia areata in children.

The combination therapy may be more effective for mild alopecia areata, especially in patients with allergies.

PFD patch helps laser tattoo removal, trichoscopy diagnoses AGA, and serum boosts SOD activity.

Higher SRD5A2 expression predicts better response to finasteride in treating urinary symptoms.

Low-dose oral minoxidil improved or stabilized hair loss in some patients, but higher doses may be needed for significant effects.

Women with androgenetic alopecia have normal levels of most blood steroids and binding proteins, but higher dehydroepiandrosterone. Some also have low "sex hormone-binding globulin" and "corticosteroide-binding globulin" capacity, and high "free androgen index" and "free cortisol index". Diane treatment can normalize these levels and improve hair conditions.

Baricitinib is a relatively safe and effective treatment for severe alopecia areata.

LC-OCT is a useful noninvasive tool for diagnosing and monitoring alopecia areata.

Baricitinib was effective and safe for severe hair loss treatment over 6 months.

Low-dose oral minoxidil is an effective and well-tolerated treatment for hair growth in alopecia patients.

Fexofenadine reduces discomfort but doesn't significantly improve hair regrowth in Alopecia Areata treatment.

Calcipotriol works almost as well as clobetasol for mild to moderate alopecia areata with fewer side effects.

The AAcQLI is a promising tool for assessing quality of life in children with alopecia areata.

There is a significant need for better-validated quality of life tools in dermatology.

Most adults with alopecia have some quality of life impairment, mainly minimal to moderate, and are treated with minoxidil.

Baseline severity, disease activity, and relapse history are key to predicting response and recurrence in alopecia areata.

Scalp medⓇ effectively and safely improves hair growth in men with androgenetic alopecia.

The treatment slightly increased hair growth and was safe for most women.

Dutasteride for hair loss can cause skin reactions like itchy red plaques.

Using both 5% spironolactone and 5% minoxidil together is safe and more effective for treating hair loss.

Deuruxolitinib effectively regrows hair in adults with alopecia areata and is well tolerated.

Experts recommend starting systemic treatment for alopecia areata when the condition is severe or causes significant distress.

Minoxidil with triamcinolone acetonide is more effective for mild alopecia areata when injected with microneedles than when applied topically.

Numerical methods help analyze alopecia drugs' properties effectively.